Latest Schedule 13G passive stakes

Fiduciary Management, Inc. has disclosed beneficial ownership of 5.4% of Hayward Holdings, Inc. common stock as of June 30, 2026.

Copeland Capital Management, LLC has disclosed beneficial ownership of over 5% of Kforce Inc.'s common stock, signaling institutional interest.

Copeland Capital Management, LLC has reported a beneficial ownership of 6.2% in Excelerate Energy, Inc. as of June 30, 2026.

Boston Partners has updated its Schedule 13G filing to reflect beneficial ownership of 0.57% in Proficient Auto Logistics, Inc.

Boston Partners has filed a Schedule 13G amendment, reporting 0% beneficial ownership of MasterBrand, Inc. common stock as of June 30, 2026.

Boston Partners has disclosed beneficial ownership of 5.17% of Valvoline Inc.'s common stock as of June 30, 2026.

Boston Partners has disclosed beneficial ownership of 17,304,271 shares, representing 7.86% of the common stock of US Foods Holding Corp. as of June 30, 2025.

Sanders Capital, LLC has reported beneficial ownership of 2,468,513 shares, representing 5.74% of the outstanding common stock of Ulta Beauty, Inc., as of June 30, 2026.

Boston Partners has disclosed beneficial ownership of 2,470,948 shares, representing 8.13% of TrueBlue, Inc.'s common stock as of June 30, 2026.

Multiple Medicxi entities have filed a Schedule 13G amendment, reporting 0.0% beneficial ownership of Centessa Pharmaceuticals plc ordinary shares as of June 30, 2026.

Boston Partners has disclosed a beneficial ownership of 5.8% in Holley Inc. common stock as of June 30, 2026.

Multiple entities have filed a joint Schedule 13G amendment to report their beneficial ownership of eToro Group Ltd. Class A common shares.

Empery Asset Management, LP, through its managed funds, has acquired a beneficial ownership of 916,532 shares, representing 7.17% of Clene Inc.'s common stock, as of June 30, 2026.

Empery Asset Management, LP and Ryan M. Lane have jointly filed a Schedule 13G, reporting beneficial ownership of 9.99% of Cellectar Biosciences, Inc. common stock, including shares issuable upon warrant exercise.

Empery Asset Management, LP and Ryan M. Lane have filed a Schedule 13G, reporting beneficial ownership of 9.99% of Lantern Pharma Inc.'s common stock, including shares issuable from warrants.

Baillie Gifford & Co. has reported a beneficial ownership of 7.5% in Denali Therapeutics Inc. common stock as of June 30, 2026.

Baillie Gifford & Co. has disclosed beneficial ownership of 15,409,837 shares, representing 5.4% of Coursera, Inc.'s common stock, as of June 30, 2026.

Baillie Gifford & Co has reported a beneficial ownership of 78,743,687 shares, representing 4.8% of Coupang, Inc.'s Class A Common Stock as of June 30, 2026.

Baillie Gifford & Co. has increased its beneficial ownership of e.l.f. Beauty, Inc. common stock to 11.9%, indicating continued institutional confidence.

Farallon Capital Management, L.L.C. and its affiliates have reported beneficial ownership of 8,365,038 shares, representing 9.4% of the common stock of Liquidia Corporation.

Farallon Capital Management and affiliated entities report beneficial ownership of 1,604,590 shares, representing 8.1% of Assembly Biosciences' common stock.

Gaotu Techedu Inc. reports significant beneficial ownership by Larry Xiangdong Chen and Ebetter International Group Limited as of June 30, 2026.

Several entities associated with Millennium Management have updated their beneficial ownership filings for Amanat Acquisition Corp, reporting a combined stake.

Bank of America Corporation /DE/ has reported a beneficial ownership of 6.7% in Total Return Securities Fund's common stock as of June 30, 2026.

Bank of America Corporation /DE/ has reported a beneficial ownership of 6.7% in Total Return Securities Fund's common stock as of June 30, 2026.

Integrated Core Strategies, Millennium Management, and Israel A. Englander have jointly reported beneficial ownership of 8.2% of Reviva Pharmaceuticals Holdings, Inc. common stock.

Daniel Mansueto has increased his beneficial ownership of Morningstar, Inc. common stock to 10.0%, holding 3,752,046 shares.

Several J.H. Whitney-affiliated entities have reported changes in their beneficial ownership of Aveanna Healthcare Holdings Inc. common stock, with one entity now holding over 7% of the outstanding shares.

RA Capital Management and its affiliates have reported beneficial ownership of 3,014,183 shares, representing 5.2% of Capricor Therapeutics' outstanding common stock.

Linden Capital L.P. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 6.9% of Willow Lane Acquisition Corp. II's Class A Ordinary Shares as of July 30, 2026.